ISSN 2097-5724 CN 61-1535/R 主管·主办:陕西省疾病预防控制中心
疾病预防与控制 Disease Prevention and Control 医学学术期刊 双月刊
2025-05-005 临床研究与药物应用 2025, (05)

吸入性糖皮质激素对哮喘儿童氧化应激水平的影响

北京大学第一医院宁夏妇女儿童医院 2.银川市第三人民医院

6下载次数 0被引频次 74阅读次数 0参考文献
知网阅读全文
摘要

摘要:目的 本研究主要探索吸入性糖皮质激素对哮喘儿童氧化应激水平的影响。方法 选择北京大学第一 医院宁夏妇女儿童医院 2023 年 3 月至 2025 年 3 月收治的 100 例哮喘患儿作为研究对象。采用随机数字表法将 100 例患儿随机分成观察组和对照组,每组 50 例。对照组患儿采用福莫特罗给药;观察组患儿采用福莫特罗联合布地奈德给药。对比分析两组的治疗有效率、氧化应激相关指标、炎症反应相关指标及不良反应发生情况。结果 相较于对照组,治疗后观察组治疗有效率、氧化应激相关指标、炎症反应相关指标及不良反应发生情况均更 优,差异具有统计学意义(P<0.05)。结论 两种药物联合使用能有效地减轻哮喘患儿的氧化损伤,抑制炎症反应,治疗效果显著,且不会增加不良反应发生概率,具备颇高的临床应用价值。

Abstract

Abstract: Objective This study aims to investigate the impact of inhaled glucocorticoids on oxidative stress levels in children with asthma. Methods A total of 100 children with asthma who were admitted to Peking University First Hospital Ningxia Women’s and Children’s Hospital from March 2023 to March 2025 were selected as the subjects. Using the random number table method, these 100 children were randomly divided into the observation group and the control group, with 50 cases in each group. Patients in the control group were treated with formoterol, while patients in the observation group were treated with formoterol combined with budesonide. The treatment efficiency, oxidative stress-related indicators, inflammatory response-related indicators and adverse reactions of the two groups were compared and analyzed. Results Compared with the control group, the treatment efficacy rate, oxidative stress-related indicators, inflammatory response-related indicators, and the occurrence of adverse reactions in the observation group were all better after treatment, and the differences were statistically significant (P<0.05). Conclusion The combination of the two drugs can effectively reduce the oxidative damage and inhibit the inflammatory response in patients with asthma. The treatment effect is significant, and it will not increase the probability of adverse reactions. It has high clinical application value.

引用本文

按标准格式复制,或导出到文献管理软件
[1]蔡婷,白园园,姚小霞.吸入性糖皮质激素对哮喘儿童氧化应激水平的影响[J],2025,01(05):.